Find Scholarly Works

Search in all content

Filters for Scholarly Works

Search concepts
Selected Filters

Publication Year

  • 2019
  • 2018
  • 2016
  • 2015
  • 2014

Author

  • Keith Lindor

ACG clinical guideline: Primary sclerosing cholangitis

Lindor, K., Kowdley, K. V. & Harrison, M. E., May 8 2015, In : American Journal of Gastroenterology. 110, 5, p. 646-659 14 p.

Research output: Contribution to journalArticle

193 Scopus citations

Advances in primary sclerosing cholangitis

Horsley-Silva, J. L., Carey, E. J. & Lindor, K., 2016, In : The Lancet Gastroenterology and Hepatology. 1, 1, p. 68-77 10 p.

Research output: Contribution to journalReview article

11 Scopus citations
5 Scopus citations

Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis

Hilscher, M., Enders, F. B., Carey, E. J., Lindor, K. & Tabibian, J. H., Mar 1 2016, In : Annals of Hepatology. 15, 2, p. 246-253 8 p.

Research output: Contribution to journalArticle

25 Scopus citations

An overview of current and future therapeutic strategies for the treatment of primary sclerosing cholangitis

Ali, A. H., Carey, E. J. & Lindor, K., Jun 2014, In : Expert Opinion on Orphan Drugs. 2, 6, p. 545-556 12 p.

Research output: Contribution to journalReview article

2 Scopus citations

Antimitochondrial Antibody–Negative Primary Biliary Cholangitis: Is It Really the Same Disease?

Chascsa, D. M. & Lindor, K., Jan 1 2018, (Accepted/In press) In : Clinics in Liver Disease.

Research output: Contribution to journalArticle

3 Scopus citations

A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis

Nevens, F., Andreone, P., Mazzella, G., Strasser, S. I., Bowlus, C., Invernizzi, P., Drenth, J. P. H., Pockros, P. J., Regula, J., Beuers, U., Trauner, M., Jones, D. E., Floreani, A., Hohenester, S., Luketic, V., Shiffman, M., Van Erpecum, K. J., Vargas, V., Vincent, C., Hirschfield, G. M. & 12 others, Shah, H., Hansen, B., Lindor, K., Marschall, H. U., Kowdley, K. V., Hooshmand-Rad, R., Marmon, T., Sheeron, S., Pencek, R., MacConell, L., Pruzanski, M. & Shapiro, D., Aug 18 2016, In : New England Journal of Medicine. 375, 7, p. 631-643 13 p.

Research output: Contribution to journalArticle

367 Scopus citations

Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis

Tabibian, J. H., Enders, F., Imam, M. H., Kolar, G., Lindor, K. & Talwalkar, J. A., 2014, In : Annals of Hepatology. 13, 3, p. 384-389 6 p.

Research output: Contribution to journalArticle

Open Access
11 Scopus citations

Association of adiposity, measures of metabolic dysregulation, and elevated alanine aminotransferase in subjects with normal body mass index

Treeprasertsuk, S., Romero-Corral, A., Somers, V. K., Sierra-Johnson, J., Lindor, K. D., Angulo, P. & Lopez-Jimenez, F., Oct 1 2014, In : Asian Biomedicine. 8, 5, p. 585-595 11 p.

Research output: Contribution to journalArticle

Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis

Musso, G., Gambino, R., Tabibian, J. H., Ekstedt, M., Kechagias, S., Hamaguchi, M., Hultcrantz, R., Hagström, H., Yoon, S. K., Charatcharoenwitthaya, P., George, J., Barrera, F., Haflidadóttir, S., Björnsson, E. S., Armstrong, M. J., Hopkins, L. J., Gao, X., Francque, S., Verrijken, A., Yilmaz, Y. & 13 others, Lindor, K. D., Charlton, M., Haring, R., Lerch, M. M., Rettig, R., Völzke, H., Ryu, S., Li, G., Wong, L. L., Machado, M., Cortez-Pinto, H., Yasui, K. & Cassader, M., Jul 2014, In : PLoS Medicine. 11, 7, e1001680.

Research output: Contribution to journalArticle

233 Scopus citations

Cancer risk, screening and surveillance in primary sclerosing cholangitis

Chascsa, D. M. & Lindor, K. D., Sep 1 2019, In : Minerva gastroenterologica e dietologica. 65, 3, p. 214-228 15 p.

Research output: Contribution to journalArticle

2 Scopus citations

Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies

Fung, B. M., Lindor, K. & Tabibian, J. H., 2019, In : World journal of gastroenterology. 25, 6, p. 659-671 13 p.

Research output: Contribution to journalReview article

13 Scopus citations

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 2015, In : Hepatology. 62, 5, p. 1620-1622 3 p.

Research output: Contribution to journalArticle

76 Scopus citations

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 2015, In : Journal of Hepatology. 63, 5, p. 1285-1287 3 p.

Research output: Contribution to journalComment/debate

47 Scopus citations

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 2015, In : Digestive and Liver Disease. 47, 11, p. 924-926 3 p., 2950.

Research output: Contribution to journalComment/debate

11 Scopus citations

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Oct 1 2015, In : Clinics and Research in Hepatology and Gastroenterology. 39, 5, p. e57-e59 800.

Research output: Contribution to journalComment/debate

20 Scopus citations

Changing nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : American Journal of Gastroenterology. 110, 11, p. 1536-1538 3 p.

Research output: Contribution to journalArticle

22 Scopus citations

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 2015, In : Gut. 64, 11, p. 1671-1672 2 p.

Research output: Contribution to journalShort survey

22 Scopus citations

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 2015, In : Gastroenterology. 149, 6, p. 1627-1629 3 p.

Research output: Contribution to journalArticle

51 Scopus citations

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 2015, In : Clinical Gastroenterology and Hepatology. 13, 11, p. 1867-1869 3 p.

Research output: Contribution to journalArticle

13 Scopus citations

Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry

Kuo, A., Gomel, R., Safer, R., Lindor, K., Everson, G. T. & Bowlus, C. L., Jun 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 7, p. 1372-1378 7 p.

Research output: Contribution to journalArticle

2 Scopus citations

Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis

Quinn, K. P., Tabibian, J. H. & Lindor, K., Dec 1 2016, (Accepted/In press) In : Scandinavian Journal of Gastroenterology. p. 1-5 5 p.

Research output: Contribution to journalArticle

11 Scopus citations

Clinical spectrum and management

Björnsson, E. S. & Lindor, K., Feb 1 2014, Autoimmune (IgG4-Related) Pancreatitis and Cholangitis. Springer New York, p. 171-179 9 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Complications, symptoms, quality of life and pregnancy in cholestatic liver disease

Zakharia, K., Tabibian, A., Lindor, K. & Tabibian, J. H., Mar 2018, In : Liver International. 38, 3, p. 399-411 13 p.

Research output: Contribution to journalReview article

15 Scopus citations

Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Younossi, Z. M., Loomba, R., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander-Tetri, B. A., Serfaty, L., Negro, F., Caldwell, S. H., Ratziu, V., Corey, K. E., Friedman, S. L., Abdelmalek, M. F., Harrison, S. A., Sanyal, A. J., Lavine, J. E., Mathurin, P., Charlton, M. R., Chalasani, N. P., Anstee, Q. M. & 4 others, Kowdley, K. V., George, J., Goodman, Z. D. & Lindor, K., Jul 2018, In : Hepatology. 68, 1, p. 361-371 11 p.

Research output: Contribution to journalReview article

105 Scopus citations

Current and promising therapy for primary biliary cholangitis

Gossard, A. A. & Lindor, K., Jun 13 2019, In : Expert Opinion on Pharmacotherapy. 20, 9, p. 1161-1167 7 p.

Research output: Contribution to journalReview article

3 Scopus citations

Current research on the treatment of primary sclerosing cholangitis

Ali, A. H., Carey, E. J. & Lindor, K., 2015, In : Intractable and Rare Diseases Research. 4, 1, p. 1-6 6 p.

Research output: Contribution to journalShort survey

26 Scopus citations

Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis

Ponsioen, C. Y., Lindor, K., Mehta, R. & Dimick-Santos, L., Sep 1 2018, In : Hepatology. 68, 3, p. 1174-1188 15 p.

Research output: Contribution to journalReview article

17 Scopus citations

Development and Validation of a Scoring System to Predict Outcomes of Patients with Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

Lammers, W. J., Hirschfield, G. M., Corpechot, C., Nevens, F., Lindor, K., Janssen, H. L. A., Floreani, A., Ponsioen, C. Y., Mayo, M. J., Invernizzi, P., Battezzati, P. M., Parés, A., Burroughs, A. K., Mason, A. L., Kowdley, K. V., Kumagi, T., Harms, M. H., Trivedi, P. J., Poupon, R., Cheung, A. & 4 others, Lleo, A., Caballeria, L., Hansen, B. E. & Van Buuren, H. R., Dec 1 2015, In : Gastroenterology. 149, 7, p. 1804-1812.e4

Research output: Contribution to journalArticle

151 Scopus citations

Diagnosis and management of primary biliary cirrhosis

Ali, A. H., Carey, E. J. & Lindor, K., Dec 1 2014, In : Expert Review of Clinical Immunology. 10, 12, p. 1667-1678 12 p.

Research output: Contribution to journalReview article

5 Scopus citations

Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

Younossi, Z. M., Loomba, R., Anstee, Q. M., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander-Tetri, B. A., Serfaty, L., Negro, F., Caldwell, S. H., Ratziu, V., Corey, K. E., Friedman, S. L., Abdelmalek, M. F., Harrison, S. A., Sanyal, A. J., Lavine, J. E., Mathurin, P., Charlton, M. R., Goodman, Z. D. & 4 others, Chalasani, N. P., Kowdley, K. V., George, J. & Lindor, K., Jul 2018, In : Hepatology. 68, 1, p. 349-360 12 p.

Research output: Contribution to journalReview article

113 Scopus citations

Distinguishing immunoglobulin G4–related disease from its pancreatobiliary mimics: Are we there now?

Tabibian, J. H. & Lindor, K., Aug 1 2016, In : Hepatology. 64, 2, p. 340-343 4 p.

Research output: Contribution to journalEditorial

6 Scopus citations

Docetaxel Induced Sclerosing Cholangitis

Horsley-Silva, J. L., Dow, E. N., Menias, C. O., Smith, M. L., Carballido, E. M., Lindor, K. D. & Vargas, H. E., Dec 1 2015, In : Digestive Diseases and Sciences. 60, 12, p. 3814-3816 3 p.

Research output: Contribution to journalArticle

8 Scopus citations

Editorial: Itching to Know: Role of Fibrates in PBC

Levy, C. & Lindor, K., Jan 1 2018, In : The American journal of gastroenterology. 113, 1, p. 56-57 2 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations
2 Scopus citations

Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses?

Tabibian, J. H. & Lindor, K., Apr 1 2018, In : Alimentary Pharmacology and Therapeutics. 47, 8, p. 1226-1227 2 p.

Research output: Contribution to journalEditorial

1 Scopus citations
8 Scopus citations

Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study

Eaton, J. E., Nelson, K. M., Gossard, A. A., Carey, E. J., Tabibian, J. H., Lindor, K. D. & LaRusso, N. F., May 4 2019, In : Scandinavian Journal of Gastroenterology. 54, 5, p. 633-639 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid

Hirschfield, G. M., Mason, A., Luketic, V., Lindor, K., Gordon, S. C., Mayo, M., Kowdley, K. V., Vincent, C., Bodhenheimer, H. C., Parés, A., Trauner, M., Marschall, H. U., Adorini, L., Sciacca, C., Beecher-Jones, T., Castelloe, E., Böhm, O. & Shapiro, D., Apr 1 2015, In : Gastroenterology. 148, 4, p. 751-761.e8

Research output: Contribution to journalArticle

280 Scopus citations

Emerging drugs for the treatment of Primary Biliary Cholangitis

Ali, A. H., Tabibian, J. H., Carey, E. J. & Lindor, K., Jan 2 2016, In : Expert Opinion on Emerging Drugs. 21, 1, p. 39-56 18 p.

Research output: Contribution to journalArticle

12 Scopus citations

Emerging therapeutic targets for primary sclerosing cholangitis

Kalani, A., Tabibian, J. H. & Lindor, K., Jul 3 2018, In : Expert Opinion on Orphan Drugs. 6, 7, p. 393-401 9 p.

Research output: Contribution to journalReview article

Erratum: Primary biliary cirrhosis (Lancet (2015) 386 (1565-1575))

Carey, E. J., Ali, A. H. & Lindor, K., 2015, In : The Lancet. 386, 10003, p. 1536 1 p.

Research output: Contribution to journalArticle

Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems

FOLD Investigators, Jan 1 2018, (Accepted/In press) In : Clinical Gastroenterology and Hepatology.

Research output: Contribution to journalArticle

12 Scopus citations

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

the GLOBAL PBC Study Group, Nov 1 2019, In : Alimentary Pharmacology and Therapeutics. 50, 10, p. 1127-1136 10 p.

Research output: Contribution to journalArticle

Open Access
7 Scopus citations

Foreword

Lindor, K., Jan 1 2014, In : Unknown Journal. p. vii-viii

Research output: Contribution to journalArticle

Hepatocellular carcinoma: Low risk of HCC in patients who have PSC and cirrhosis

Gossard, A. A. & Lindor, K., May 2014, In : Nature Reviews Gastroenterology and Hepatology. 11, 5, p. 276-277 2 p.

Research output: Contribution to journalArticle

6 Scopus citations

Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis

Cholankeril, G., Gonzalez, H. C., Satapathy, S. K., Gonzalez, S. A., Hu, M., Khan, M. A., Yoo, E. R., Li, A. A., Kim, D., Nair, S., Wong, R. J., Kwo, P. Y., Harrison, S. A., Younossi, Z. M., Lindor, K. & Ahmed, A., Jun 2018, In : Clinical Gastroenterology and Hepatology. 16, 6, p. 965-973.e2

Research output: Contribution to journalArticle

8 Scopus citations

Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment

Fibrotic Liver Disease Consortium Investigators, Aug 1 2018, In : Clinical Gastroenterology and Hepatology. 16, 8, p. 1342-1350.e1

Research output: Contribution to journalArticle

16 Scopus citations

Joint society statement for the elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Oct 1 2016, In : Journal of Hepatology. 65, 4, p. 661-662 2 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Joint society statement for the elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Oct 1 2016, In : Hepatology. 64, 4, p. 1031-1032 2 p.

Research output: Contribution to journalEditorial

4 Scopus citations